Table 3.
Disease | OMIM# | Gene | Inheritance | PI3K signaling | Immunological defect | Neurodevelopmental delay | References |
---|---|---|---|---|---|---|---|
APDS1 | 615513 | PIK3CD | AD | Increased | Ig serum level, B and T | 19% of patients in cohort study;global development, speech delay, autism spectrum disorder | (5, 25) |
APDS2 | 616005 | PIK3R1 | AD | Increased | Ig serum level, B and T | 31% of patients in cohort study; cognitive impairments, learning disabilities | (4) |
SHORT syndrome | 269880 | PIK3R1 | AD | Decreased | N.R. | Behavioral problemsspeech delay | (26, 27) |
p85α deficiency | 615214 | PIK3R1 | AR | N.R. | B absent, Ig serum level, | N.R. | (23) |
P110delta deficiency | PIK3CD | AR | Decreased | B and NK decreased, T impaired Ig serum level, | N.R. | (20, 22, 24) | |
Roifman–Chitayat syndrome | 613328 | PIK3CD/KNSTRN | AR | Ig serum level, B and NK decreased, T impaired | Developmental delay; cognitive, speech, and motor retardation,tremor, ataxia | (19) | |
APDS-L/Cowden syndrome1/macrocephaly/autism syndrome | 158350/605309 | PTEN | AD | Increased | Ig serum level, B and T | Autism spectrum disorders; developmental delay and macrocephaly | (28–32) |
NK, natural killer; N.R., not reported.